Breaking Finance News

Humana Inc (NYSE:HUM) stock price target increased to $257.00, issued a research note today by Zacks Investment Research

In a report released on Thursday May 25, 2017 Zacks Investment Research increased the stock price target of Humana Inc (NYSE:HUM) to $257.00 indicating a possible upside of 0.11%.

Yesterday Humana Inc (NYSE:HUM) traded -1.28% lower at $231.35. The company’s 50-day moving average is $244.96 and its 200-day moving average is $238.02. The last closing price is down 7.41% from the 200-day moving average, compared to the S&P 500 which has increased 0.02% over the same time period. 1,374,098 shares of the stock traded hands, up from an average trading volume of 1,077,400

See Chart Below

Humana Inc (NYSE:HUM)

Humana Inc has a 52 week low of $165.03 and a 52 week high of $264.56 with a P/E ratio of 21.03 The company’s market cap is currently $0.

In addition to Zacks Investment Research reporting its stock price target, a total of 15 brokers have issued a research note on the company. The average stock price target is $205.93 with 3 brokers rating the stock a strong buy, 3 brokers rating the stock a buy, 13 brokers rating the stock a hold, 0 brokers rating the stock a underperform, and finally 0 brokers rating the stock a sell.

General Information About Humana Inc (NYSE:HUM)

Humana Inc. is a health and well-being company. The Company's segments include Retail, Group and Specialty, Healthcare Services and Individual Commercial. The Retail segment consists of Medicare benefits, as well as individual commercial fully insured medical and specialty health insurance benefits, including dental, vision, and other supplemental health and financial protection products. The Group and Specialty segment consists of employer group commercial fully insured medical and specialty health insurance benefits, including dental, vision, and other supplemental health. The Healthcare Services segment includes services offered to its health plan members, as well as to third parties, including pharmacy solutions, provider services, home-based services and clinical programs, as well as services and capabilities to manage population health. The Individual Commercial segment includes Individual Commercial products marketed under the HumanaOne brand.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with MarketBeat.com's FREE daily email newsletter.

Leave a Reply

Your email address will not be published. Required fields are marked *